Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
53.50
+0.50 (0.94%)
Feb 13, 2026, 4:08 PM HKT

HKG:2315 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
34,7103,3954,78510,245--
Market Cap Growth
1000.06%-29.05%-53.29%---
Enterprise Value
34,8543,5624,68210,003--
Last Close Price
53.508.5011.9825.65--
PE Ratio
146.6195.11----
PS Ratio
26.603.256.0616.97--
PB Ratio
35.333.805.507.87--
P/TBV Ratio
36.203.925.738.12--
P/FCF Ratio
93.5318.32----
P/OCF Ratio
82.2615.10----
EV/Sales Ratio
26.713.415.9316.57--
EV/EBITDA Ratio
84.3611.58----
EV/EBIT Ratio
150.4422.29----
EV/FCF Ratio
93.9219.23----
Debt / Equity Ratio
0.690.680.690.360.070.06
Debt / EBITDA Ratio
1.501.80----
Debt / FCF Ratio
1.813.28----
Asset Turnover
0.480.400.270.210.15-
Inventory Turnover
33.6026.8012.256.096.11-
Quick Ratio
1.511.221.011.251.553.16
Current Ratio
1.891.531.251.521.963.49
Return on Equity (ROE)
16.11%4.12%-39.45%-50.12%-40.27%-
Return on Assets (ROA)
6.20%3.86%-6.94%-14.81%-14.02%-
Return on Invested Capital (ROIC)
21.05%12.36%-31.99%-71.53%-76.89%-62.32%
Return on Capital Employed (ROCE)
12.10%8.00%-15.60%-27.60%-28.00%-18.10%
Earnings Yield
0.42%1.05%-8.82%-6.64%--
FCF Yield
1.07%5.46%-4.68%-6.00%--
Buyback Yield / Dilution
0.31%0.08%-4.54%-5.13%-180.82%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.